| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > International Trade Impact |
|
E-Folder - International Trade Impact
International trade has become increasingly important to the world economy as well as th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e U.S. economy. Trade accounts for about 25 percent of U.S. and world gross domestic pro ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in uct (GDP). It is growing at twice the rate of any other economic sector. In terms of the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. United States, one-third of the small firms that make an exportable product and would li here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e to export do not presently export what they manufacture. Of the small U.S. firms that d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro o export, nearly two-thirds export to only one country. The international flows of good ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc and capital that underlie international finance are critically important to the well-be easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ng of the world's nations. United Nations statistics show that the ratio of world export nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to total gross domestic product has consistently increased since 1970. Much of this gro and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ th in world trade can be attributed to the liberalization of trade and investment becaus ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi of reductions in tariffs, quotas, currency controls, and other restrictions on the flow ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a of international payments. In addition, the advances in communications and transportatio dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod facilities and their concomitant reductions in cost have also facilitated the growth in cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin international trade. Much of the trade liberalization has been accomplished by the imple tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen entation of several regional economic agreements and organizations. Several regional ec t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nomic agreements or organizations have been established since the end of World War II fo ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the purpose of facilitating an expansion of trade. The governments involved in these ef y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products orts have recognized the value of expanded trade. Some of these blocs have committed to . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de he major objective of reducing or eliminating trade barriers such as tariffs and quotas. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Others have gone further and have established political as well as economic institutions tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Principle(s) of Negative Value - A Procurement Article The Art of Leadership: Part One
|